Vaccines and adjuvants – Special Issue

References

1. Baz Morelli A. , Becher D. , Koernig S. , Silva A. , Drane D. , Maraskovsky E. . ( 2012; ). ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases. . J Med Microbiol 61:, 935––943.[CrossRef]
   [Google Scholar]
2. Bijker E. M. , Sauerwein R. W. . ( 2012; ). Enhancement of naturally acquired immunity against malaria by drug use. . J Med Microbiol 61:, 904––910.[PubMed] [CrossRef]
   [Google Scholar]
3. Edwards J. E. Jr . ( 2012; ). Fungal cell wall vaccines: an update. . J Med Microbiol 61:, 895––903.[PubMed] [CrossRef]
   [Google Scholar]
4. Kool M. , Fierens K. , Lambrecht B. N. . ( 2012; ). Alum adjuvant: some of the tricks of the oldest adjuvant. . J Med Microbiol 61:, 927––934.[PubMed] [CrossRef]
   [Google Scholar]
5. Oyston P. C. , Robinson K. . ( 2012; ). The current challenges for vaccine development. . J Med Microbiol 61:, 889––894.[PubMed] [CrossRef]
   [Google Scholar]
6. Terra V. S. , Mills D. C. , Yates L. E. , Abouelhadid S. , Cuccui J. , Wren B. W. . ( 2012; ). Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design. . J Med Microbiol 61:, 919––926.[PubMed] [CrossRef]
   [Google Scholar]
7. Williamson D. , Oyston P. C. F. . ( 2012; ). The natural history and incidence of Yersinia pestis and prospects for vaccination. . J Med Microbiol 61:, 911––918.[PubMed] [CrossRef]
   [Google Scholar]